Michael P. Sheets

2.5k total citations
22 papers, 967 citations indexed

About

Michael P. Sheets is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Michael P. Sheets has authored 22 papers receiving a total of 967 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Organic Chemistry. Recurrent topics in Michael P. Sheets's work include Click Chemistry and Applications (4 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Michael P. Sheets is often cited by papers focused on Click Chemistry and Applications (4 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Michael P. Sheets collaborates with scholars based in United States, United Kingdom and Switzerland. Michael P. Sheets's co-authors include Russell C. Petter, Mariana Nacht, William Westlin, Juswinder Singh, Margit Hagel, Christoph Lengauer, Timothy J. Guzi, Joseph L. Kim, Prasoon Chaturvedi and Nooreen Rubin and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Cancer Research.

In The Last Decade

Michael P. Sheets

22 papers receiving 943 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael P. Sheets United States	13	584	203	161	153	152	22	967
Indrasish Ray Chaudhuri United States	16	642 1.1×	113 0.6×	250 1.6×	126 0.8×	244 1.6×	26	1.1k
Olusegun Williams United States	7	996 1.7×	304 1.5×	143 0.9×	69 0.5×	191 1.3×	7	1.3k
Sadao Kuromitsu Japan	19	500 0.9×	92 0.5×	118 0.7×	75 0.5×	214 1.4×	39	1.1k
Nanni Huser United States	8	737 1.3×	82 0.4×	79 0.5×	73 0.5×	238 1.6×	15	999
Kevin Hudson United Kingdom	17	779 1.3×	53 0.3×	132 0.8×	76 0.5×	223 1.5×	30	1.1k
Theonie Anastassiadis United States	5	602 1.0×	76 0.4×	82 0.5×	57 0.4×	181 1.2×	6	817
Ronald E. Savage United States	20	632 1.1×	136 0.7×	150 0.9×	283 1.8×	341 2.2×	43	1.3k
Chris J. Novotny United States	9	642 1.1×	66 0.3×	131 0.8×	81 0.5×	179 1.2×	10	829
Kee Chuan Goh Singapore	16	596 1.0×	158 0.8×	154 1.0×	82 0.5×	389 2.6×	26	1.1k
Wei Wei Prior United States	8	644 1.1×	131 0.6×	53 0.3×	66 0.4×	199 1.3×	10	888

Countries citing papers authored by Michael P. Sheets

Since Specialization

Citations

This map shows the geographic impact of Michael P. Sheets's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. Sheets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. Sheets more than expected).

Fields of papers citing papers by Michael P. Sheets

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael P. Sheets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. Sheets. The network helps show where Michael P. Sheets may publish in the future.

Co-authorship network of co-authors of Michael P. Sheets

This figure shows the co-authorship network connecting the top 25 collaborators of Michael P. Sheets. A scholar is included among the top collaborators of Michael P. Sheets based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael P. Sheets. Michael P. Sheets is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hatlen, Megan, Oleg Schmidt-Kittler, Cori Ann Sherwin, et al.. (2019). Acquired On-Target Clinical Resistance Validates FGFR4 as a Driver of Hepatocellular Carcinoma. Cancer Discovery. 9(12). 1686–1695. 90 indexed citations

Rahal, Rami, Erica N Evans, Wei Hu, et al.. (2016). Abstract 2641: The development of potent, selective RET inhibitors that target both wild-type RET and prospectively identified resistance mutations to multi-kinase inhibitors. Cancer Research. 76(14_Supplement). 2641–2641. 10 indexed citations

Hagel, Margit, Chandra Miduturu, Michael P. Sheets, et al.. (2015). First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway. Cancer Discovery. 5(4). 424–437. 247 indexed citations

Hoeflich, Klaus P., Margit Hagel, Chandra Miduturu, et al.. (2015). O048 : First selective small molecule inhibitor of FGFR4 for the treatment of hepatocellular carcinomas with an activated FGFR4 signaling pathway. Journal of Hepatology. 62. S215–S216. 1 indexed citations

Evans, Erica N, Richland Tester, Russell Karp, et al.. (2013). Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans. Journal of Pharmacology and Experimental Therapeutics. 346(2). 219–228. 171 indexed citations

Singh, Juswinder, Erica N Evans, Margit Hagel, et al.. (2012). Superiority of a novel EGFR targeted covalent inhibitor over its reversible counterpart in overcoming drug resistance. MedChemComm. 3(7). 780–780. 13 indexed citations

Evans, Erica N, Richland Tester, Prasoon Chaturvedi, et al.. (2011). Clinical Development of AVL-292; A Potent, Selective Covalent Btk Inhibitor for the Treatment of B Cell Malignancies,. Blood. 118(21). 3485–3485. 19 indexed citations

Evans, Erica N, Sabine Ponader, Russell Karp, et al.. (2011). 2.23 Covalent Inhibition of Btk with Clinical Development Compound AVL-292 Disrupts Signaling That Maintains the Microenvironment Necessary for Chronic Lymphocytic Leukemia Growth. Clinical Lymphoma Myeloma & Leukemia. 11. S173–S174. 10 indexed citations

Hagel, Margit, Deqiang Niu, Thia St Martin, et al.. (2010). Selective irreversible inhibition of a protease by targeting a noncatalytic cysteine. Nature Chemical Biology. 7(1). 22–24. 77 indexed citations

10.

Hagel, Margit, Lixin Qiao, Thia St Martin, et al.. (2010). 764 AVL-181, A POTENT AND SELECTIVE IRREVERSIBLE HCV PROTEASE INHIBITOR, REQUIRES A HELPER AMINO ACID IN THE BINDING MICROENVIRONMENT TO FORM A COVALENT BOND WITH CYS-159. Journal of Hepatology. 52. S297–S297. 2 indexed citations

11.

Evans, Erica N, Michael P. Sheets, Hugues Bernard, et al.. (2008). Prolonged Inhibition of BCR Signaling and Suppression of B Cell Lymphoma through Irreversible Inhibition of Bruton’s Tyrosine Kinase. Blood. 112(11). 2608–2608. 4 indexed citations

12.

Chen, Yung‐Wu, Morey L. Smith, Michael P. Sheets, et al.. (2007). Zotarolimus, a Novel Sirolimus Analogue With Potent Anti-proliferative Activity on Coronary Smooth Muscle Cells and Reduced Potential for Systemic Immunosuppression. Journal of Cardiovascular Pharmacology. 49(4). 228–235. 55 indexed citations

13.

Smith, Morey L., Stephen J. Ballaron, Michael P. Sheets, et al.. (2002). TH1 and TH2 cytokine inhibition by 3,5-bis(trifluoromethyl)pyrazoles, a novel class of immunomodulators. Cellular Immunology. 220(2). 134–142. 27 indexed citations

14.

Trevillyan, James M., X. Grace Chiou, Yung‐Wu Chen, et al.. (2001). Potent Inhibition of NFAT Activation and T Cell Cytokine Production by Novel Low Molecular Weight Pyrazole Compounds. Journal of Biological Chemistry. 276(51). 48118–48126. 85 indexed citations

15.

Warrior, Usha, X. Grace Chiou, Michael P. Sheets, et al.. (1999). Development of a p38 Kinase Binding Assay for High Throughput Screening. SLAS DISCOVERY. 4(3). 129–135. 7 indexed citations

16.

Mollison, Karl W., Thomas A. Fey, Donna M. Gauvin, et al.. (1999). A Macrolactam Inhibitor of T Helper Type 1 and T Helper Type 2 Cytokine Biosynthesis for Topical Treatment of Inflammatory Skin Diseases1. Journal of Investigative Dermatology. 112(5). 729–738. 10 indexed citations

17.

Chen, Yung‐Wu, Morey L. Smith, Michael P. Sheets, et al.. (1999). Ex VivoAssessment of Immunosuppression in Undiluted Whole Blood from Pigs Dosed with Tacrolimus (FK506). Clinical Immunology. 90(1). 133–140. 3 indexed citations

18.

Trevillyan, James M., X. Grace Chiou, Stephen J. Ballaron, et al.. (1999). Inhibition of p56lckTyrosine Kinase by Isothiazolones. Archives of Biochemistry and Biophysics. 364(1). 19–29. 28 indexed citations

19.

Lane, Ben, Karl W. Mollison, Kennan C. Marsh, et al.. (1998). Synthesis and immunosuppressant activity of pyrazole carboxamides. Bioorganic & Medicinal Chemistry Letters. 8(19). 2787–2792. 18 indexed citations

20.

Sheets, Michael P., Usha Warrior, Ho Sup Yoon, et al.. (1998). A High-Capacity Scintillation Proximity Assay for the Discovery and Evaluation of ZAP-70 Tandem SH2 Domain Antagonists. SLAS DISCOVERY. 3(2). 139–144. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact